OncoCyte Corp (OCX)
2.66
-0.12
(-4.30%)
USD |
NASDAQ |
May 03, 16:00
2.69
+0.03
(+1.13%)
After-Hours: 20:00
OncoCyte Free Cash Flow: -23.61M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.61M |
| September 30, 2023 | -29.23M |
| June 30, 2023 | -39.21M |
| March 31, 2023 | -44.74M |
| December 31, 2022 | -49.91M |
| September 30, 2022 | -46.92M |
| June 30, 2022 | -46.05M |
| March 31, 2022 | -42.35M |
| December 31, 2021 | -38.19M |
| September 30, 2021 | -37.03M |
| June 30, 2021 | -32.19M |
| March 31, 2021 | -30.97M |
| December 31, 2020 | -27.21M |
| September 30, 2020 | -27.10M |
| June 30, 2020 | -25.42M |
| March 31, 2020 | -20.82M |
| December 31, 2019 | -20.63M |
| Date | Value |
|---|---|
| September 30, 2019 | -16.88M |
| June 30, 2019 | -14.52M |
| March 31, 2019 | -15.65M |
| December 31, 2018 | -11.68M |
| September 30, 2018 | -12.57M |
| June 30, 2018 | -13.58M |
| March 31, 2018 | -12.93M |
| December 31, 2017 | -13.48M |
| September 30, 2017 | -12.73M |
| June 30, 2017 | -10.27M |
| March 31, 2017 | -8.752M |
| December 31, 2016 | -7.628M |
| September 30, 2016 | -7.211M |
| June 30, 2016 | -7.554M |
| March 31, 2016 | -6.736M |
| December 31, 2015 | -4.729M |
Free Cash Flow Range, Past 5 Years
-49.91M
Minimum
Dec 2022
-14.52M
Maximum
Jun 2019
-32.26M
Average
-30.97M
Median
Mar 2021
Free Cash Flow Benchmarks
| Fonar Corp | 12.18M |
| XWELL Inc | -18.45M |
| ProPhase Labs Inc | -14.50M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 34.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.562M |
| Cash from Investing (Quarterly) | 0.241M |
| Cash from Financing (Quarterly) | -0.03M |
| Free Cash Flow Per Share (Quarterly) | -0.5838 |
| Free Cash Flow to Equity (Quarterly) | -4.826M |
| Free Cash Flow Yield | -116.1% |